HOME >> BIOLOGY >> NEWS
Key regulatory enzyme is a molecular 'octopus'

of constant stimulation," said Lefkowitz. "Years ago, we had discovered that this down-regulation occurs due to a phosphorylation of the activated receptor that triggers binding of a protein called beta arrestin. This protein stops further G protein signaling and acts as an adaptor and scaffolding that connects to other signaling molecules."

Thus, the cellular "stop signal" not only turns off the G protein, but immediately tags the receptor for recycling into the cell interior and turns on other signaling pathways, said Lefkowitz. His laboratory identified that enzyme as GRK, but a central mystery was how the family of GRK enzymes fulfills their intricate regulatory duties.

In the latest work the researchers deduced the structure of GRK2, the member of the GRK enzyme family that is active in heart muscle and many other tissues.

Critical to solving that mystery was obtaining the three-dimensional structure of GRK2 using X-ray crystallography. In this technique, pure crystals of a protein are bombarded by an intense X-ray beam, and the protein structure is deduced by analyzing the pattern of the beam's diffraction. This structural determination was done by co-author John Tesmer and his colleagues.

The resulting structure revealed the details of three regions, or domains, of the GRK2 enzyme, which had earlier been identified by biochemical studies in the Lefkowitz laboratory:

  • The central, or catalytic domain is the region that triggers the phosphorylation reaction
  • The "regulator of G protein signaling homology" (RH) domain attaches to the G protein to switch it off, and
  • The "PH" domain enables GRK2 to home in on the G protein at the cell membrane and attach to it.

To reveal how GRK2 interacts with the G protein, the researchers obtained the structure of GRK2 attached to a subunit of the G protein to which it normally binds, or complexes. Lefkowitz noted that a particularly striking achievem
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University
19-Jun-2003


Page: 1 2 3

Related biology news :

1. Significant strides in small regulatory RNA research in plants
2. Pew report finds GM insects may offer benefits, but clear regulatory oversight is lacking
3. Researchers discover genes that control regulatory functions in malaria mosquitoes
4. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
5. First glimpse of DNA binding to viral enzyme
6. Two enzymes key to calorie-burning, Brown research shows
7. Argonne scientists determine structure of staph, anthrax enzyme
8. Brain serotonin enzyme finding might explain psychiatric disorders
9. Study finds plant enzyme function changes with location in cell
10. Basic RNA enzyme research promises single-molecule biosensors
11. Molecule that blocks key bacterial enzyme may lead to new antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Key regulatory enzyme molecular octopus

(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... , June 17, 2015 QIAGEN ... launched new Investigator ® STR assay kits for analysis ... United States . The new genetic fingerprint kits provide ... (short tandem repeats or STRs) for DNA matching. They incorporate ... of DNA in each sample, a novel QIAGEN technology that ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/2/2015)... PALO ALTO, Calif. (PRWEB) , ... July 02, 2015 , ... ... designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June ... and functionality: Luzi's voice command technology makes it effortless to use, while the integration ...
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
Breaking Biology Technology:Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
Cached News: